Healthpeak Properties (NYSE:DOC – Free Report) had its price target decreased by Robert W. Baird from $25.00 to $24.00 in a research report report published on Tuesday,Benzinga reports. Robert W. Baird currently has an outperform rating on the real estate investment trust’s stock.
Several other equities analysts have also recently commented on DOC. Wells Fargo & Company dropped their target price on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their target price for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Mizuho dropped their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. StockNews.com cut shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Finally, Morgan Stanley raised shares of Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a report on Wednesday, January 15th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and a consensus price target of $24.08.
Get Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Price Performance
Healthpeak Properties Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Friday, February 14th will be given a $0.305 dividend. The ex-dividend date is Friday, February 14th. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.23%. Healthpeak Properties’s payout ratio is 342.87%.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently modified their holdings of DOC. HM Payson & Co. purchased a new stake in shares of Healthpeak Properties during the third quarter worth about $25,000. S.A. Mason LLC purchased a new stake in shares of Healthpeak Properties during the third quarter worth about $26,000. Fortitude Family Office LLC purchased a new stake in shares of Healthpeak Properties during the third quarter worth about $32,000. Barrett & Company Inc. purchased a new stake in shares of Healthpeak Properties during the third quarter worth about $33,000. Finally, Harvest Fund Management Co. Ltd purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth about $30,000. 93.57% of the stock is owned by institutional investors.
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- High Flyers: 3 Natural Gas Stocks for March 2022
- META Stock: Insider Selling Ramps Up—What It Means for Investors
- What is the S&P/TSX Index?
- 3 Chip Stocks Still Trading 50% Below Their 52-Week Highs
- How to Calculate Stock Profit
- U.S. Steel: Will Trump-Backed Nippon Investment Drive Upside?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.